These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34974814)

  • 1. Prostate-specific membrane antigen modulates the progression of prostate cancer by regulating the synthesis of arginine and proline and the expression of androgen receptors and Fos proto-oncogenes.
    Hong X; Mao L; Xu L; Hu Q; Jia R
    Bioengineered; 2022 Jan; 13(1):995-1012. PubMed ID: 34974814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel regulation of PSMA and PSA expression by Q640X AR in 22Rv1 and LNCaP prostate cancer cells.
    Ben Jemaa A; Sallami S; Céraline J; Oueslati R
    Cell Biol Int; 2013 May; 37(5):464-70. PubMed ID: 23418075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Androgen Receptor Activity on Prostate-Specific Membrane Antigen Expression in Prostate Cancer Cells.
    Sommer U; Siciliano T; Ebersbach C; Beier AK; Stope MB; Jöhrens K; Baretton GB; Borkowetz A; Thomas C; Erb HHH
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35162969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and identification of significant genes related to tumor metastasis and PSMA in prostate cancer using microarray analysis.
    Xu L; Wang Z; Li XF; He X; Guan LL; Tuo JL; Wang Y; Luo Y; Zhong HL; Qiu SP; Cao KY
    Oncol Rep; 2013 Oct; 30(4):1920-8. PubMed ID: 23917490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: implications for PSA surrogacy.
    Kuroda K; Liu H; Kim S; Guo M; Navarro V; Bander NH
    Prostate; 2009 Oct; 69(14):1579-85. PubMed ID: 19575420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT7 depletion inhibits cell proliferation and androgen-induced autophagy by suppressing the AR signaling in prostate cancer.
    Ding M; Jiang CY; Zhang Y; Zhao J; Han BM; Xia SJ
    J Exp Clin Cancer Res; 2020 Feb; 39(1):28. PubMed ID: 32019578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen.
    Evans MJ; Smith-Jones PM; Wongvipat J; Navarro V; Kim S; Bander NH; Larson SM; Sawyers CL
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9578-82. PubMed ID: 21606347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
    Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
    Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific membrane antigen knockdown impairs the tumorigenicity of LNCaP prostate cancer cells by inhibiting the phosphatidylinositol 3-kinase/Akt signaling pathway.
    Guo Z; Lai Y; Du T; Zhang Y; Chen J; Bi L; Lin T; Liu H; Wang W; Xu K; Jiang C; Han J; Zhang C; Dong W; Huang J; Huang H
    Chin Med J (Engl); 2014; 127(5):929-36. PubMed ID: 24571890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
    Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
    Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSMA redirects cell survival signaling from the MAPK to the PI3K-AKT pathways to promote the progression of prostate cancer.
    Caromile LA; Dortche K; Rahman MM; Grant CL; Stoddard C; Ferrer FA; Shapiro LH
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor.
    Kuroda K; Liu H
    Int J Oncol; 2019 Apr; 54(4):1357-1366. PubMed ID: 30720063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p,p'-Dichlorodiphenyltrichloroethane (p,p'-DDT) and p,p'-dichlorodiphenyldichloroethylene (p,p'-DDE) repress prostate specific antigen levels in human prostate cancer cell lines.
    Wong LI; Labrecque MP; Ibuki N; Cox ME; Elliott JE; Beischlag TV
    Chem Biol Interact; 2015 Mar; 230():40-9. PubMed ID: 25682698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
    Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
    Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox7 negatively regulates prostate-specific membrane antigen (PSMA) expression through PSMA-enhancer.
    Peng W; Guo L; Tang R; Liu X; Jin R; Dong JT; Xing CG; Zhou W
    Prostate; 2019 Mar; 79(4):370-378. PubMed ID: 30488457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.
    Rubenstein M; Hollowell CM; Guinan P
    Med Oncol; 2012 Jun; 29(2):835-41. PubMed ID: 21573974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-acetyl-L-aspartyl-L-glutamate peptidase-like 2 is overexpressed in cancer and promotes a pro-migratory and pro-metastatic phenotype.
    Whitaker HC; Shiong LL; Kay JD; Grönberg H; Warren AY; Seipel A; Wiklund F; Thomas B; Wiklund P; Miller JL; Menon S; Ramos-Montoya A; Vowler SL; Massie C; Egevad L; Neal DE
    Oncogene; 2014 Nov; 33(45):5274-87. PubMed ID: 24240687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of short-term Dutasteride treatment on prostate-specific membrane antigen expression in a mouse xenograft model.
    Kranzbühler B; Sousa R; Prause L; Burger IA; Rupp NJ; Sulser T; Salemi S; Eberli D
    Cancer Rep (Hoboken); 2021 Dec; 4(6):e1418. PubMed ID: 34008909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.